New funding for capital expenditure and working capital
Filed with ASX · · 4 pages · English
Earlier from Jatcorp
- Coronavirus and manufacturing update
- JAT to develop antiviral food supplement
- Coronavius update and record monthly revenue achieved
- Coronavirus update
- Increased lactoferrin range sales due to coronavirus
Later from Jatcorp
- Creation of New Brand and Release of New Products
- Announcement of buy-back - Appendix 3C
- Appendix 4E & Full Year Statutory Accounts
- JAT delivers new products and distribution partnership
- Quarterly Activities Report
Follow Jatcorp into a list and get an email when it puts out news.
Follow Jatcorp